“genentech” Archives

in
Entry Author Date Location
Merck Is Latest to Tout Success as Lung Cancer Drug Combos Plow Forward 01/16/18 New York
Eye Drug Delivery Firm Eyenovia Sets IPO Range as Plans Come Into Focus 01/10/18 New York
Bio Roundup: Tax Cuts, Drug Approval Record, New Flagship Cash & More 12/22/17 National
Gene Therapy Advances, But Hemophilia Is No Easy Target 12/13/17 National
In Biggest Biotech IPO of 2017, Denali Raises $248M for Neuro Drugs 12/08/17 San Francisco
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1) 12/04/17 National
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More 12/01/17 National
As AMD Race Tightens, Regeneron’s Second Eye Drug Combo Falls Short 11/27/17 New York
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
Bio Roundup: ICER Eyes Cost, Azar at HHS, Gates’s ALZ Cash & More 11/17/17 National
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning 11/16/17 San Francisco
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal 09/14/17 San Diego
23andMe Raises $250M For Consumer Disease-Risk Tests, Drug R&D 09/12/17 San Francisco
Jazz Pharma, ImmunoGen Strike Up Drug Pact in Leukemia and More 08/29/17 Boston
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Ophthotech’s Final Try at Combo Eye Drug Comes up Short 08/14/17 New York
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug 08/01/17 Boston
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Genentech’s Hemophilia Drug Slashes Bleeding Rates, Early Data Show 06/26/17 San Francisco
In Maine, Making Cancer DNA Tests Free—And Asking Tough Questions 05/31/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
Page 1 of 20 next page »